Wird geladen...
Drug Development for Severe Asthma: What Are the Metrics?
Although reversible airway obstruction in part defines asthma, lung function as measured by spirometry alone inadequately predicts the value of new therapeutic agents in the treatment of severe asthma. Our objectives are 1) to review whether pulmonary function and bronchodilator reversibility are en...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
2012
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3383351/ https://ncbi.nlm.nih.gov/pubmed/22627271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2012.05.005 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|